Choosing Appropriate Estimands in Clinical Trials-Reference-Cited by-同舟云学术

Choosing Appropriate Estimands in Clinical Trials

Published:2015-07 Issue:4 Volume:49 Page:584-592
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Leuchs Ann-Kristin,Zinserling Jörg,Brandt Andreas,Wirtz Dorothee,Benda Norbert

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479014567317.pdf

Reference32 articles.

1. Mallinckrodt CH. Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide. New York: Cambridge University Press; 2013.

2. National Research Council: Panel on Handling Missing Data in Clinical Trials. The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: National Academies Press; 2010.

3. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York: John Wiley & Sons; 1987.

4. Molenberghs G, Kenward MG. Missing Data in Clinical Studies. New York: John Wiley & Sons; 2007.

5. Molenberghs G. Incomplete data in clinical studies: analysis, sensitivity, and sensitivity analysis. Drug Inf J. 2009;43:409–429.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles for Defining Estimands in Clinical Trials—A Proposal;Pharmaceutical Statistics;2024-08-13

2. Current developments of the estimand concept;Pharmaceutical Statistics;2024-04-27

3. The estimands framework: a primer on the ICH E9(R1) addendum;BMJ;2024-01-23

4. Appropriately estimating the standardized average treatment effect with missing data: A simulation and primer;Behavior Research Methods;2022-12-22

5. Contrasting principal stratum and hypothetical strategy estimands in multi‐period crossover trials with incomplete data;Biometrics;2022-11-23